@article{324704c8f3a44bb2ad94f9ff5b35fa23,
title = "Epigenome-wide association study reveals CpG sites associated with thyroid function and regulatory effects on KLF9",
abstract = "Background: Thyroid hormones play a key role in differentiation and metabolism and are known regulators of gene expression through both genomic and epigenetic processes including DNA methylation. The aim of this study was to examine associations between thyroid hormones and DNA methylation. Methods: We carried out a fixed-effect meta-analysis of epigenome-wide association study (EWAS) of blood DNA methylation sites from 8 cohorts from the ThyroidOmics Consortium, incorporating up to 7073 participants of both European and African ancestry, implementing a discovery and replication stage. Statistical analyses were conducted using normalized beta CpG values as dependent and log-transformed thyrotropin (TSH), free thyroxine, and free triiodothyronine levels, respectively, as independent variable in a linear model. The replicated findings were correlated with gene expression levels in whole blood and tested for causal influence of TSH and free thyroxine by two-sample Mendelian randomization (MR). Results: Epigenome-wide significant associations (p-value Conclusions: We report novel associations between TSH, thyroid hormones, and blood-based DNA methylation. This study advances our understanding of thyroid hormone action particularly related to KLF9 and serves as a proof-of-concept that integrations of EWAS with other -omics data can provide a valuable tool for unraveling thyroid hormone signaling in humans by complementing and feeding classical in vitro and animal studies. ",
keywords = "thyroid function, DNA methylation, KLF9, Mendelian randomization, gene expression",
author = "Antoine Weihs and Layal Chaker and Martin, {Tiphaine C} and Braun, {Kim V E} and Campbell, {Purdey J} and Cox, {Simon R.} and Myriam Fornage and Christian Gieger and Grabe, {Hans J} and Harald Grallert and Sarah Harris and Brigitte Kuhnel and Marioni, {Riccardo E} and Nicholas Martin and McCartney, {Daniel L} and Mcrae, {Allan F.} and Christa Meisinger and {van Meurs}, {Joyce B. J.} and Jana Nano and Matthias Nauck and Annette Peters and Holger Prokisch and Michael Roden and Elizabeth Selvin and Marian Beekman and {van Heemst}, Diana and Slagboom, {P Eline} and Swenson, {Brenton R.} and Adrienne Tin and Pei-Chien Tsai and Uitterlinden, {Andre G} and Visser, {W. Edward} and Henry V{\"o}lzke and Melanie Waldenberger and Walsh, {John P} and Anna K{\"o}ttgen and Wilson, {Scott G.} and Peeters, {Robin P.} and Bell, {Jordana Tzenova} and Marco Medici and Alexander Teumer",
note = "Funding Information: H.J.G. has received travel grants and speakers honoraria from Fresenius Medical Care, Neuraxpharm, Servier, and Janssen Cilag as well as research funding from Fresenius Medical Care not related to this work. R.E.M. has received speaker fees from Illumina and is an advisor to the Epigenetic Clock Development Foundation. All other authors declare no conflicts of interest. ",
year = "2023",
month = mar,
day = "16",
doi = "10.1089/thy.2022.0373",
language = "English",
volume = "33",
pages = "301–311",
journal = "Thyroid Journal Program",
issn = "1050-7256",
publisher = "Mary Ann Liebert",
number = "3",
}